Skip to content

T BIL BR9766Recalls & reported problems

Randox Laboratories Limited · The device is intended for the quantitative in vitro determination of total bilirubin in serum or plasma. · Class 2

Data updated Oct 13, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
0
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

No MAUDE adverse event reports in our data reference this device identifier directly.

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Recalls naming this device

  1. Oct 11, 2023Open, Classified

    Randox has had reports of elevated patient results using Plasma (lithium heparin) samples with Total Bilirubin reagent (TBil) Vanadate Oxidation Method.

    Z-0501-2024 · Root cause: Device Design · FDA record ↗

Other Enzymatic Method, Bilirubin devices

All Enzymatic Method, Bilirubin devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page